Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “celecoxib” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 11
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 11 pipeline programs matching "celecoxib" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

11 results for “celecoxib” Back to intelligence hub

Search results

  1. Celecoxib

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 small molecule completed

    1 trial
  2. Celecoxib

    United Therapeutics Europe Ltd

    Head and Neck Cancer

    phase 2 small molecule terminated

    1 trial
  3. Celecoxib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oral Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial
  4. Doxazosin 4 mg daily plus Celecoxib 200 mg every day (QD)

    Hospital Authority, Hong Kong

    Benign Prostatic Hyperplasia

    phase 2 small molecule completed

    1 trial
  5. Fixed dose combination Ciprofloxacin/Celecoxib

    NeuroSense Therapeutics

    Amyotrophic Lateral Sclerosis

    phase 2 small molecule completed

    1 trial
  6. Celecoxib

    Akebia Europe Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  7. Fixed dose combination Ciprofloxacin/Celecoxib

    NeuroSense Therapeutics

    ALS (Amyotrophic Lateral Sclerosis)

    phase 1 small molecule completed

    1 trial
  8. Celecoxib

    Pfizer

    Arthritis, Juvenile Rheumatoid

    approved small molecule completed

    1 trial
  9. pregabalin and celecoxib

    Pfizer

    Chronic Low Back Pain With a Neuropathic Component

    approved small molecule terminated

    1 trial
  10. Celecoxib

    The First People's Hospital of Lianyungang

    Low Back Pain

    small molecule completed

    1 trial
  11. Celecoxib 400mg

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Peutz-Jeghers Syndrome

    small molecule active

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.